{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "340",
                "355"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "Nie zastosowano"
        },
        {
            "identifier": "T2",
            "position": [
                "356",
                "382"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "leczenia farmakologicznego"
        },
        {
            "identifier": "T3",
            "position": [
                "492",
                "544"
            ],
            "subtype": "Behaviour",
            "type": "T",
            "value": "Dalsze ograniczanie intensywnego wysi\u0142ku fizycznego."
        },
        {
            "identifier": "T4",
            "position": [
                "545",
                "583"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "W dniu 10 maja 2018r. o godzinie 11:00"
        },
        {
            "identifier": "T5",
            "position": [
                "643",
                "650"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "badanie"
        },
        {
            "identifier": "T6",
            "position": [
                "652",
                "707"
            ],
            "subtype": "Behaviour",
            "type": "T",
            "value": "Nale\u017cy pozosta\u0107 na czczo przez 4 godziny przed badaniem"
        },
        {
            "identifier": "T7",
            "position": [
                "709",
                "727"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "Do 7 dni wcze\u015bniej"
        },
        {
            "identifier": "T8",
            "position": [
                "758",
                "784"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "badanie poziomu kreatyniny"
        },
        {
            "identifier": "T9",
            "position": [
                "958",
                "993"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "niedomykalno\u015bci\u0105 zastawki aortalnej"
        },
        {
            "identifier": "T10",
            "position": [
                "1027",
                "1035"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "uczulony"
        },
        {
            "identifier": "T11",
            "position": [
                "1065",
                "1079"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "lek\u00f3w na sta\u0142e"
        },
        {
            "identifier": "T12",
            "position": [
                "1080",
                "1093"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "nie otrzymuje"
        },
        {
            "identifier": "T13",
            "position": [
                "811",
                "821"
            ],
            "subtype": "Investigation",
            "type": "T",
            "value": "badanie MR"
        },
        {
            "icd": "ICD10:I35.1",
            "identifier": "N1",
            "referenced": "T9",
            "subtype": "Reference",
            "type": "N",
            "value": "Niedomykalno\u00c5\u009b\u00c4\u0087 zastawki aortalnej"
        },
        {
            "icd": "ICD10:Z91.0",
            "identifier": "N2",
            "referenced": "T10",
            "subtype": "Reference",
            "type": "N",
            "value": "Uczulenie na czynniki inne ni\u00c5\u00bc leki i substancje biologiczne w wywiadzie"
        },
        {
            "arg1": "T12",
            "arg2": "T11",
            "identifier": "R3",
            "subtype": "Neg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 18 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: m\u0119ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nNie zastosowano leczenia farmakologicznego.\n------------------------------------------------\nZalecenia\n------------------------------------------------\nDalsze ograniczanie intensywnego wysi\u0142ku fizycznego.\nW dniu 10 maja 2018r. o godzinie 11:00  prosz\u0119 zg\u0142osi\u0107 si\u0119 do Pracowni Rezonansu Magnetycznego na badanie. Nale\u017cy pozosta\u0107 na czczo przez 4 godziny przed badaniem. Do 7 dni wcze\u015bniej prosz\u0119 ambulatoryjnie wykona\u0107 badanie poziomu kreatyniny i wynik zabra\u0107 ze sob\u0105 na badanie MR.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nch\u0142opiec z niedomykalno\u015bci\u0105 zastawki aortalnej skierowany na badania kontrolne, uczulony na roztocza kurzu domowego , lek\u00f3w na sta\u0142e nie otrzymuje\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:6.99[10\\\\^3/ul]\n    RBC:5.05[10\\\\^6/ul]\n    HGB:15.6[g/dl]\n    HCT:45.2[%]\n    MCV:89.5[fl]\n    MCH:30.9[pg]\n    MCHC:34.5[g/dl]\n    PLT:221.0[10\\\\^3/ul]\n    RDW-SD:42.1[fl]\n    RDW-CV:12.8[%]\n    PDW:14.9[fl]\n    MPV:11.5[fl]\n    P-LCR:37.1[%]\n    PCT:0.3[%]\n    NEUTR#:3.95[10\\\\^3/ul]\n    NEUTR%:56.5[%]\n    LYMPH#:2.24[10\\\\^3/ul]\n    LYMPH%:32.0[%]\n    MONO#:0.57[10\\\\^3/ul]\n    MONO%:8.20[%]\n    EO#:0.19[10\\\\^3/ul]\n    EO%:2.70[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.60[%]\n    NRBC %:0.10[%]\n    NRBC#:0.01[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.347\n    pCO2:55.9[mmHg]\n    BE:3.00[mmol/L]\n    HCO3:29.8[mmol/L]\n    pO2:31.6[mmHg]\n    O2Sat:50.5[%]\n    Na - ABL:143[mmol/L]\n    K - ABL:4.4[mmol/L]\n    Cl - ABL:105[mmol/L]\n    Ca zj ABL:1.29[mmol/L]\n    Ht - ABL:48.3[%]\n    Hb ABL:15.8[g/dl]\n    FO2Hb:49.8[%]\n    FCOHb:0.8[%]\n    FMetHb:0.6[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:101[mg/dl]\n    mleczany:19[mg/dl]\n    COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:164.0[ng/ml]\nFibrynogen (F): FIB:1.72[g/L]\nAntytrombina III (ATIII): ATIII:107.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:31.3[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.3[s]\nCzas trombinowy (TT): TT:16.4[s]\nWap\u0144 ca\u0142kowity: Ca:2.47[mmol/L]\nMagnez: Mg:0.87[mmol/L]\nCholesterol: CHOL:118.00[mg/dl]\nBilirubina ca\u0142kowita TBIL: TBIL:0.90[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:89[%]\nBia\u0142ko ca\u0142kowite: TP:7.60[g/dl]\nKreatynina: CREA:1.00[mg/dl]\nMocznik: UREA:27.00[mg/dl]\nASPAT: AST:20.00[IU/L]\nALAT: ALT:39.00[IU/L]\nPLT z morfologii: PLT:221.0[10\\\\^3/ul]\nNT- proBNP: NTpBNP:39.50[pg/ml]\nTSH: TSH:4.42[uIU/ml]\nGlukoza w surowicy: GLU-sur:89[mg/dl]\nPosiew - Wymaz z nosa: POSIEW:\nPosiew - Wymaz z odbytu: POSIEW:\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:73.1[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:177[cm]\neGFR (13-18r\u017c M) stand.wg.Schwartza  wsp. 0.700: eGFR13-18M:123.9[ml/min/1,73m2]\nFT3 III: FT3 III:4.16[pg/ml]\nFT4II: FT4II:1.62[ng/dl]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ23.0\nQ23.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n------------------------------------------------"
}